// App-Quantinova.ai

PB1502 : OUTCOMES IN PATIENTS WITH FOLLICULAR LYMPHOMA AND CHRONIC LYMPHOID LEUKEMIA RECEIVING OBINUTUZUMAB, IN THE SETTING OF COVID19 INFECTION

Researchers

Presenter

  • Adela Perolla

Principal Investigators

  • Nora ollaku

  • Alma Cili

  • Elsuarta alliku

  • Tatjana Caja

  • Polikron Pulluqi

  • Arben Ivanaj

Medical Centers

  • Hematology,UHC ' Mother Teresa',Tirana,阿尔巴尼亚

Locations

  • Albania

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Follicular lymphoma

  • Lymphomas

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Obinutuzumab

  • Obinutuzumab Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved